News
Kimmins' HISTurn project receives Innovation Funding
Published: 2 February 2022
Led by Dr. Sarah Kimmins, Department of Animal Science and Pharmacology and Therapeutics, HISTurn is one of three Prelaunch Phase projects awarded support through the University’s Innovation Fund. This fertility diagnostic technology fills a health needs gap by accurately diagnosing infertility in men and providing clinicians with actionable information to allow them to streamline fertility treatment pathways. The team aims to make the clinical journey for couples inclusive of men and to increase the births of healthy children.
Learn more about the HisTurn project at McGill’s Innovation page.
See the full list of Innovation Fun winner in the .